等待开盘 01-31 09:30:00 美东时间
+0.095
+1.60%
今日重点评级关注:Oppenheimer:维持Pelthos Therapeutics"跑赢大市"评级,目标价从57美元升至60美元;Small Cap Consumer Research:维持Lands' End"买入"评级,目标价从20美元升至45美元
01-27 10:02
An announcement from ImmunityBio ( ($IBRX) ) is now available. On January 23, 2...
01-26 20:33
ImmunityBio Amends Convertible Note to Allow Partial Debt-to-Equity Conversion ImmunityBio Inc. announced an amendment to its $505 million convertible note with Nant Capital, allowing the noteholder to convert any portion of the debt into company shares before the note matures. No other changes to t
01-26 20:08
ImmunityBio Forms Biotech Alliance with Saudi Partners ImmunityBio Inc. has taken part in the USA–Saudi Biotech Alliance Summit, marking the beginning of a new era in healthspan, immunotherapy, and global scientific partnership. This collaboration aims to advance innovative healthcare solutions and
01-26 15:54
ImmunityBio Reports Promising Survival Data for ANKTIVA Plus CAR-NK in Recurrent Glioblastoma Trial ImmunityBio Inc. has announced updated Phase 2 clinical results from the QUILT 3.078 trial (NCT06061809) evaluating a chemotherapy-free combination immunotherapy regimen, ANKTIVA® plus CAR-NK, in pati
01-26 14:52
今日重点评级关注:RBC Capital:维持Compass Pathways"跑赢大市"评级,目标价从16美元升至21美元;RBC Capital:维持GH Research"跑赢大市"评级,目标价从33美元升至40美元
01-26 14:32
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. Monday - January 2...
01-24 04:00
BUZZ-ImmunityBio releases early brain cancer treatment trial data; shares down ** Shares of drug developer ImmunityBio IBRX.O fall 3% to $7.13 premarket ** Co says 19 of 23 patients in its ongoing study for recurrent glioblastoma, an aggressive brain cancer, remain alive after treatment, with median
01-23 21:27
英特尔期权成交翻倍,看涨期权集体飙升最高涨850%!美光股价创新高,多张看涨期权大涨超200%;IBRX期权大异动,资金押注长期催化剂>>
01-22 15:00
截止1月22日10点11分,上证指数涨0.54%,深证成指涨0.45%,创业板指涨0.58%。油气开采及服务、可燃冰、军工装备等板块涨幅居前。 ETF方面,标普...
01-22 10:59